Revised Consolidated Statements of Operations
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended March 31, 2025 |
|
|
|
As reported |
|
|
Adjustments |
|
|
As revised |
|
Provision for (benefit from) income taxes |
$ |
|
4 |
|
$ |
|
1 |
|
$ |
|
5 |
|
Net (loss) income |
$ |
|
(4 |
) |
$ |
|
(1 |
) |
$ |
|
(5 |
) |
Net (loss) income attributable to Chemours |
$ |
|
(4 |
) |
$ |
|
(1 |
) |
$ |
|
(5 |
) |
Revised Consolidated Statements of Comprehensive (Loss) Income
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended March 31, 2025 |
|
|
|
As reported |
|
|
Adjustments |
|
|
As revised |
|
Net loss |
$ |
|
(4 |
) |
$ |
|
(1 |
) |
$ |
|
(5 |
) |
Unrealized (loss) gain on net investment hedge (Pre-Tax) |
$ |
|
(31 |
) |
$ |
|
5 |
|
$ |
|
(26 |
) |
Unrealized (loss) gain on net investment hedge (Tax) |
$ |
|
8 |
|
$ |
|
(1 |
) |
$ |
|
7 |
|
Unrealized (loss) gain on net investment hedge (After-Tax) |
$ |
|
(23 |
) |
$ |
|
4 |
|
$ |
|
(19 |
) |
Hedging activities, net (Pre-Tax) |
$ |
|
(38 |
) |
$ |
|
5 |
|
$ |
|
(33 |
) |
Hedging activities, net (Tax) |
$ |
|
9 |
|
$ |
|
(1 |
) |
$ |
|
8 |
|
Hedging activities, net (After-Tax) |
$ |
|
(29 |
) |
$ |
|
4 |
|
$ |
|
(25 |
) |
Other Comprehensive income (loss) |
$ |
|
29 |
|
$ |
|
4 |
|
$ |
|
33 |
|
Comprehensive income |
$ |
|
25 |
|
$ |
|
3 |
|
$ |
|
28 |
|
Comprehensive income attributable to Chemours |
$ |
|
25 |
|
$ |
|
3 |
|
$ |
|
28 |
|
Revised Consolidated Statements of Stockholders' Equity
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three months ended March 31, 2025 |
|
|
|
As reported |
|
|
Adjustments |
|
|
As revised |
|
Retained earnings at 1/1/2025 |
$ |
|
1,701 |
|
$ |
|
(16 |
) |
$ |
|
1,685 |
|
Total Equity 1/1/2025 |
$ |
|
588 |
|
$ |
|
(16 |
) |
$ |
|
572 |
|
Net loss |
$ |
|
(4 |
) |
$ |
|
(1 |
) |
$ |
|
(5 |
) |
Other Comprehensive Income |
$ |
|
29 |
|
$ |
|
4 |
|
$ |
|
33 |
|
Accumulated Other Comprehensive Income at 3/31/2025 |
$ |
|
(338 |
) |
$ |
|
4 |
|
$ |
|
(334 |
) |
Retained earnings at 3/31/2025 |
$ |
|
1,659 |
|
$ |
|
(17 |
) |
$ |
|
1,642 |
|
Total Equity 3/31/2025 |
$ |
|
580 |
|
$ |
|
(13 |
) |
$ |
|
567 |
|
Revised Consolidated Statements of Cash Flows
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
Three Months Ended March 31, 2025 |
|
|
|
As reported |
|
|
Adjustments |
|
|
As revised |
|
Net loss |
$ |
|
(4 |
) |
$ |
|
(1 |
) |
$ |
|
(5 |
) |
Cash flows from operating activities: |
|
|
|
|
|
|
|
|
|
Deferred tax (benefit) provision |
$ |
|
(15 |
) |
$ |
|
1 |
|
$ |
|
(14 |
) |
Cash provided by (used for) operating activities |
|
|
(112 |
) |
|
|
— |
|
|
|
(112 |
) |
|